Redesign Science
New York, US · Founded 2019 · Delaware corporation · 3 known investors
Software platform to improve drug discovery
AI & Machine LearningBiotechDeep Tech
Founders & leadership
DW
David William RooklinExecutive Officer, Director
AT
Andrew Tucker AvornCorporate Secretary
HL
Haotian LiDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$5MraisedJul 2021 · 10 investors · BiotechnologyRule 506(b)
▶$5MraisedJul 2021 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David ` RooklinExecutive Officer, Director
- Ted JingDirector
- Haotian LiDirector
- Andrew AvornExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.7MraisedOct 2019 · 9 investors · BiotechnologyRule 506(b)
▶$1.7MraisedOct 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David William RooklinExecutive Officer, Director
- Andrew Tucker AvornExecutive Officer
- Haotian LiDirector
- Offering amount
- $2.4M
- Amount sold
- $1.7M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.